Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

- PMLiVE

AstraZeneca gains rights to Usynova’s KRAS inhibitor in deal worth almost $420m

There are currently no approved drugs specifically targeting the KRAS G12D mutation

Can Cinderella save us?

Study finds AI detects AMR faster than gold-standard testing

The method detected AMR with at least 80% accuracy on a per-cell basis, within 30 minutes

- PMLiVE

UK’s Autumn Budget details measures to boost life sciences sector

The new budget will aim to advance research and manufacturing in the UK

- PMLiVE

The rise of digital healthcare – fuelled by open innovation in healthtech hubs

How the ever-increasing uptake of digital solutions is enhancing patient engagement, increasing access to care and lowering the cost of drug development

- PMLiVE

Healthcare in the age of AI: How will artificial intelligence impact future decision-making?

Authored by: Constanza Salas, Jhon Galindo and Rachel Howard

Inizio

- PMLiVE

Medscape Medical Affairs Celebrate a High Commendation at the PMEAs

Last night the Medscape Medical Affairs team gathered in London for the Pharmaceutical Marketing Excellence Awards (PMEAs) where their entries, Transatlantic Exchanges: Artificial Intelligence and Data Science in Oncology and...

Medscape Medical Affairs

Ease and Effectiveness of Knowledge Sharing; the top 10 benefits of virtual advisory boards

Here's another great tip on why the benefits of virtual advisory boards are superior to in-person and hybrid advisory boards. #8. The Ease and Effectiveness of Sharing Knowledge and Data...

Impetus Digital

- PMLiVE

23rd PMEA celebrate excellence in pharmaceutical marketing

This year’s Awards were held at the Sheraton Park Lane in London and included 14 categories

- PMLiVE

Boehringer Ingelheim to acquire T3 Pharmaceuticals in deal worth over $500m

The acquisition marks a significant boost to Boehringer’s immuno-oncology portfolio

- PMLiVE

Levofloxacin revealed as first effective treatment for multi-drug resistant TB

UCL researchers found that levofloxacin prevented MDR-TB by 60%

- PMLiVE

You have to start somewhere

Why Biden’s healthcare policy changes will be remembered for decades to come

- PMLiVE

Landmark UK medicines deal to save NHS £14bn in medicine costs

The agreement will help provide lifesaving treatments and care for NHS patients

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links